Showing results (901-910 of 3,473) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|March 10, 2018
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic ImpairmentErik Mogalian, Diana M Brainard, Anu Osinusi, et al.
Clinical Pharmacokinetics|March 10, 2018
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and PharmacogeneticsFemke M de Man, Andrew K L Goey, Ron H N van Schaik, et al.
Clinical Pharmacokinetics|February 19, 2018
Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug-Drug Interactions Involving Enzyme ModulationChia-Hsiang Hsueh, Vicky Hsu, Yuzhuo Pan, et al.
Clinical Pharmacokinetics|February 15, 2018
Augmented Renal Clearance in Critically Ill Patients: A Systematic ReviewIdoia Bilbao-Meseguer, Alicia Rodríguez-Gascón, Helena Barrasa, et al.
Clinical Pharmacokinetics|December 14, 2017
Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal AnesthesiaZoubir Djerada, Catherine Feliu, Yoann Cazaubon, et al.
Clinical Pharmacokinetics|November 16, 2017
Obesity and Altered Aspirin PharmacologyNicholas B Norgard
Clinical Pharmacokinetics|October 30, 2017
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult PatientsPiergiorgio Cojutti, Manjunath P Pai, Federico Pea
Clinical Pharmacokinetics|February 23, 2018
Author Correction: Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction?Jennifer H Martin, Jennifer Schneider, Catherine J Lucas, et al.
Clinical Pharmacokinetics|March 3, 2007
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosingAlexander Teml, Elke Schaeffeler, Klaus R Herrlinger, et al.
Clinical Pharmacokinetics|March 3, 2007
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolitesJaakko Puttonen, Sampo Kantele, Matti Kivikko, et al.
Pageof 348